• Genoa in the News

Genoa pharmacist featured in Chain Drug Review’s “Excellence in Pharmacy Practice” profile series

Oct 27th, 2024

Kristen Pyland, a Genoa pharmacist who saved the life of a woman experiencing an overdose, was recently featured by Chain Drug Review in a pharmacy profile series highlighting the important role of pharmacists within their communities.

In the article, Pyland shared the personal experience that inspired her to become a pharmacist and detailed how her Genoa pharmacy supports the behavioral health community.   

“It’s extremely difficult for someone to decide to get treatment and stay true to that promise to themselves,” Pyland said.  “So, when they do, I’m dedicated to providing the support and care they need to be successful, and I’m grateful for the opportunity to help people make a positive change in their life.”

Read the full article here or view it in Chain Drug Review’s recent issue.

Recent Posts


  • 340B
340B made easy: 5 traits to look for in a contract pharmacy partner

The 340B Drug Pricing Program helps participating organizations – or covered entities – use savings on prescription drug costs to offer more comprehensive services and care for more eligible patients....

  • Behavioral Health
  • Clinical Insights
  • Treatment
Quick guide to recently approved behavioral health medications

Keeping up with new and emerging treatment options for your consumers can be difficult. Genoa Healthcare’s Tim Krause, PharmD, compiled a quick guide to share the latest on recently approved...

  • Clinical Insights
  • Treatment
Long-acting injectables in practice: What providers need to know

Genoa Healthcare recently hosted a webinar where Senior Product Manager Blake Shoemaker, PharmD, discussed long-acting injectables (LAIs) in practice. Watch the recording below for an overview on benefits, challenges and...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....